--:--:--

Sun Pharma Advanced Research Company Limited

Web: sparc.life NSE: SPARC BSE: 532872 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

174 6(-3%)

Volume

51L as on 24, Jun

Open

161

High

203

Low

200

Close

179

VWAP

233

52 Week High

289

52 Week Low

108

Viand Research Rating
Quality Score

52/100

Growth Score

100/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

5,630

No. of Shares

32.4

P/E

-16.14

P/B

-83.39

Face Value

1

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

516.23

ROCE

-

Profit Growth

-

Listing Date

18-Jul-07

Rank/Sector Rank

#778/#73

Promoter Holding

65.68%

FII Holding

3.9%

DII Holding

0.09%

Price Chart
Price Performance
1 Week5%
1 Month8%
3 Months103%
6 Months82%
1 Year42%
YTD82%
Moving Average
5 Day SMA236
10 Day SMA232
20 Day SMA220
30 Day SMA210
50 Day SMA186
61 Day SMA175
80 Day SMA156
200 Day SMA174
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 3253238249251
Resistance 2249237245248
Resistance 1242236242240
Pivot Point238235238237
Support 1231234234230
Support 2227233231226
Support 3220232227219
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqNP Qtr Rs.Cr.
1SUNPHARMA4,21,79317580%5%4%4%3755.50.0711509
2DIVISLAB2,43,22291622%0%45%38%6955.502568
3TORNTPHARM1,75,54746152%5%10%28%7255.51.792138
4ZYDUSLIFE1,13,21711350%1%20%12%2055.50.313560
5APOLLOHOSP1,09,34176042%9%4%1%5855.50.92003
6LAURUSLABS1,08,19820021%8%83%124%055.50.48890
7CIPLA1,07,52013312%2%8%19%2255.50.023862
8DRREDDY1,03,41412393%8%1%4%2055.50.24158
9MANKIND93,99322764%1%8%7%4955.50.391938
10AUROPHARMA92,68816112%1%20%52%055.50.192415
Load More
Shareholding Pattern (%)
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Promoters(0.01) 65.68%(0.01) 65.67%(0.01) 65.67%(0.01) 65.67%(0.01) 65.67%(0.01) 65.68%(0.01) 65.68%(0.01) 65.68%(0.01) 65.68%(0.01) 65.68%(0.01) 65.68%(0.01) 65.68%(0.01) 65.68%(-2.61) 65.68%(-0.91) 68.23%(0.01) 69.09%(0.01) 69.09%(1.01) 69.09%(0.01) 68.10%(0.01) 68.10%
FIIs(1.91) 3.90%(0.01) 2.04%(0.31) 2.04%(0.31) 1.76%(0.01) 1.47%(-0.81) 1.45%(0.11) 2.23%(-0.51) 2.15%(-0.61) 2.64%(-0.11) 3.24%(-0.41) 3.30%(0.01) 3.67%(0.01) 3.64%(0.21) 3.64%(1.11) 3.48%(0.01) 2.38%(0.01) 2.40%(-0.11) 2.38%(0.01) 2.51%(0.01) 2.54%
DIIs(-0.81) 0.09%(0.11) 0.88%(-0.31) 0.78%(0.11) 1.05%(-0.21) 0.97%(0.51) 1.13%(0.41) 0.64%(0.01) 0.21%(-0.51) 0.17%(0.01) 0.67%(0.01) 0.67%(0.01) 0.65%(0.01) 0.63%(-0.11) 0.63%(0.01) 0.76%(0.01) 0.76%(0.01) 0.76%(0.21) 0.76%(0.01) 0.55%(0.01) 0.56%
Public30.34%31.41%31.51%31.52%31.88%31.76%31.47%31.96%31.51%30.41%30.36%29.99%30.06%30.04%27.53%27.77%27.75%27.77%28.84%28.81%
No. of Shareholders141,957140,625144,810136,997140,724142,864131,034128,205125,184102,743103,990101,433100,80798,77796,33793,71894,49492,73695,03994,834
Quarterly Results
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Sales4018538810271513171714212448
Sales Growth % (YoY)314%6716%-43%-39%-43%64%8%-39%-30%-65%-89%-33%-16%-
Sales Growth % (QoQ)-97.8%23062.5%--20%-63%80%15.4%-23.5%-21.4%-33.3%-12.5%-50%-
Expenses74806574628189117112124116113126137
Operating Profit-341773-57-66-52-54-74-104-95-108-103-91-102-90
OPM %-8696-673-838-543-198-499-808-566-649-740-432-427-188
Other Income242-120900024681011
Interest812986531110000
Depreciation22333333333333
Profit before tax-211761-81-76-52-61-80-108-97-107-100-86-95-82
Tax %00000000000000
Net Profit -211761-81-76-52-61-80-108-97-107-100-86-95-82
Net Profit Growth % (QoQ)-101.2%2274.1%-6.6%-46.2%14.8%23.8%25.9%-11.3%9.3%-7%-16.3%9.5%-15.9%-
Net Profit Growth % (YoY)59.6%2986.9%-1.2%29.6%46.4%43%20%-25.6%-2.1%-30.5%----
TTM Net Profit15831552-270-269-301-346-392-412-390-388-363-263-1770
EPS in Rs-0.6554.26-2.48-2.34-1.6-1.88-2.46-3.32-2.98-3.29-3.07-2.66-2.94-2.53
Profit and Loss
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales187972762391372537718378181161156
Sales Growth %2518%-5%-68%74%-46%229%-58%134%-57%12%4%-7%
Expenses281399479453324388387334321304224191
Operating Profit1598-327-404-214-187-135-310-151-243-123-63-35
OPM %85-456-534-90-136-53-404-83-310-68-39-23
Other Income-222911751014541433
Interest349281311300220
Depreciation101112121011988887
Profit before tax1552-345-388-223-203-151-312-145-197-119-70-40
Tax %000000000000
Net Profit 1552-345-388-223-203-151-312-145-197-119-70-40
Net Profit Growth %549.9%11.1%-74%-9.9%-34.4%51.6%-115.2%26.4%-65.5%-70%-75%-
EPS in Rs47.83-10.64-11.96-6.86-7.48-5.77-11.92-5.55-7.85-4.82-2.83-1.6
Dividend Payout %000000000000
Cash Flows
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity-239-362-429-69-208-152-211-172-183-128-44-41
Cash from Investing Activity-24158391-548-292155-102-105-7-1353
Cash from Financing Activity262201436172291595527422419451-1
Net Cash Flow-1-44-1-8900-6360-711
Balance Sheet
Mar 2026Sep 2025Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital32323232322726262625252424
Reserves1301-377-253924804-194-45270160133876
Borrowings55941726556167923667223564
Other Liabilities2752502843053021701622241011221117539
Total Liabilities2168322329486830280230273398309273163143
Fixed Assets851629510310692911045852697067
CWIP72154442726532243110
Investments000229112682111081000
Other Assets20111601793384061501271281061461929276
Total Assets2168322329486830280230273398309273163143
Delivery

Delivery Data: SPARC

#Date
172
23%
212
Value (Cr)Q/T
53		Del
41		Del
10
122-Oct173
12
36405
221-Oct179
15
49436
319-Oct185
7
40423
416-Oct189
8
49353
515-Oct188
11
41435
614-Oct192
26
51308
713-Oct189
13
55355
812-Oct185
10
31384
99-Oct186
15
34386
108-Oct188
24
364310
117-Oct197
21
70286
126-Oct197
13
71466
135-Oct191
16
46457
141-Oct194
21
55388
1530-Sep197
28
495415
1629-Sep209
30
493811
1728-Sep203
26
583910
1825-Sep209
46
753316
1924-Sep204
18
49387
2023-Sep206
40
693414
2122-Sep198
18
55427
2221-Sep196
13
56375
2318-Sep194
13
65486
2417-Sep193
16
58386
2516-Sep186
12
56496
2615-Sep188
12
46526
2711-Sep196
9
48464
2810-Sep197
14
62446
299-Sep201
10
64495
308-Sep203
13
58405
317-Sep206
31
673812
324-Sep199
12
60476
333-Sep203
21
69327
342-Sep200
49
762512
351-Sep197
16
57396
3631-Aug199
44
713616
3728-Aug208
44
723817
3827-Aug195
16
53325
3926-Aug194
6
49503
4025-Aug194
6
47443
4124-Aug195
7
50544
4221-Aug197
5
55513
4320-Aug200
17
53336
4419-Aug193
8
52464
4518-Aug193
14
62568
4617-Aug197
10
64505
4714-Aug198
19
685711
Daily Market Cap
DateTotal Market CapChangeChg %
22-Oct5,630c179c3.07
21-Oct5,809c195c3.24
19-Oct6,003c161c2.61
17-Oct6,164c00
16-Oct6,164c63c1.04
15-Oct6,101c252c3.96
14-Oct6,352c207c3.37
13-Oct6,145c169c2.83
12-Oct5,975c49c0.81
09-Oct6,024c77c1.26
08-Oct6,101c234c3.69
05-Oct6,335c73c1.14
01-Oct6,408c209c3.15
29-Sep6,617c29c0.44
28-Sep6,587c66c0.99
25-Sep6,653c126c1.93
24-Sep6,527c105c1.63
22-Sep6,422c250c4.05
17-Sep6,172c250c3.89
10-Sep6,422c00
Stock Checklist
Price is above from 52 week high low average: 36%
Stock is trading above all short term SMAs: YES
Stock is trading above all long term SMAs: YES
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: YES
Promoters are buying the stock: YES
Mutual Fund Holdings

Held by 16 fund scheme(s) across 6 fund house(s) as of Oct26 · Total value ₹12 Cr · 2 increasing / 0 decreasing · View in MF Pro →

Fund HouseSchemesWeight %ChangeValue (Cr)
Motilal Oswal Mutual Fund40.20%+0.01%10.1
Samco Mutual Fund20.36%+0.08%1.9
Groww Mutual Fund20.01%-0.1
Bandhan Mutual Fund40.03%-0
Angel One Mutual Fund20.02%-0
Mirae Asset Mutual Fund20.00%-0
Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
For research & education only — not investment advice. Not a SEBI-registered Investment Adviser or Research Analyst. Data may be delayed or inaccurate. Investments in securities markets are subject to market risks.
0